Indian stocks snapped a four-day losing streak on Monday. Top indices, S&P BSE Sensex and NSE Nifty50 extended gains after a cautious start. The Sensex...
Glenmark Pharma said it had received approval from the Drug Controller General of India (DCGI) to conduct phase 1 clinical trials of its molecule, GRC...
The US health regulator, US FDA, has approved Glenmark Pharmaceuticals Ltd’s Teriflunomide tablets, which used to treat multiple sclerosis into the US market. The approved...
One of India’s largest pharmaceutical company, Glenmark Pharma, reported their net consolidated profit for the June-end quarter of the current fiscal year at Rs. 232.99...
Glenmark Pharma has received final approval for Colesevelam Hydrochloride, from USFDA. Colesevelam Hydrochloride is a generic version of Welchol 1 of Daiichi Sankyo Inc and the...
Glenmark Pharma’s subsidiary Glenmark Specialty, has entered into an exclusive licensing agreement with Australia’s Seqirus to commercialize its nasal spray, Ryaltris in Australia and New...
The US Food & Drug Administration (USFDA) has given its first supplemental abbreviated new drug applications (ANDA) approval, to the Glenmark Pharma’s manufacturing facility in Monroe, North...
Glenmark Pharmaceuticals has submitted a new drug application for its nasal spray Ryaltris, with the US health regulator. In a BSE filing the company stated,...